News

4TEEN4 Announces Publication In European Journal Of Heart Failure Demonstrating First-In-Human Shock Reversal Evidence For Procizumab In Three Compassionate Use Cases
Data from three terminally ill cardiogenic shock patients showcase potential of procizumab to safely reverse shock within 48 hours and p ...
Pharmabiz1h
US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%
US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%: Berlin Wednesday, July 16, 2025, 13:00 H ...